158 related articles for article (PubMed ID: 33496909)
1. RSF1 requires CEBP/β and hSNF2H to promote IL-1β-mediated angiogenesis: the clinical and therapeutic relevance of RSF1 overexpression and amplification in myxofibrosarcomas.
Li CF; Chan TC; Wang CI; Fang FM; Lin PC; Yu SC; Huang HY
Angiogenesis; 2021 Aug; 24(3):533-548. PubMed ID: 33496909
[TBL] [Abstract][Full Text] [Related]
2. PAK1 overexpression promotes myxofibrosarcoma angiogenesis through STAT5B-mediated
Li CF; Chan TC; Fang FM; Yu SC; Huang HY
Int J Biol Sci; 2023; 19(12):3920-3936. PubMed ID: 37564209
[TBL] [Abstract][Full Text] [Related]
3. AMACR amplification in myxofibrosarcomas: a mechanism of overexpression that promotes cell proliferation with therapeutic relevance.
Li CF; Fang FM; Lan J; Wang JW; Kung HJ; Chen LT; Chen TJ; Li SH; Wang YH; Tai HC; Yu SC; Huang HY
Clin Cancer Res; 2014 Dec; 20(23):6141-52. PubMed ID: 25384383
[TBL] [Abstract][Full Text] [Related]
4. Remodeling and spacing factor 1 (RSF1) deposits centromere proteins at DNA double-strand breaks to promote non-homologous end-joining.
Helfricht A; Wiegant WW; Thijssen PE; Vertegaal AC; Luijsterburg MS; van Attikum H
Cell Cycle; 2013 Sep; 12(18):3070-82. PubMed ID: 23974106
[TBL] [Abstract][Full Text] [Related]
5. Post-Translational Regulation of the RSF1 Chromatin Remodeler under DNA Damage.
Min S; Choi YW; Yun H; Jo S; Ji JH; Cho H
Mol Cells; 2018 Feb; 41(2):127-133. PubMed ID: 29385673
[TBL] [Abstract][Full Text] [Related]
6. ASS1 as a novel tumor suppressor gene in myxofibrosarcomas: aberrant loss via epigenetic DNA methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevance.
Huang HY; Wu WR; Wang YH; Wang JW; Fang FM; Tsai JW; Li SH; Hung HC; Yu SC; Lan J; Shiue YL; Hsing CH; Chen LT; Li CF
Clin Cancer Res; 2013 Jun; 19(11):2861-72. PubMed ID: 23549872
[TBL] [Abstract][Full Text] [Related]
7. RSF1 is a positive regulator of NF-κB-induced gene expression required for ovarian cancer chemoresistance.
Yang YI; Ahn JH; Lee KT; Shih IeM; Choi JH
Cancer Res; 2014 Apr; 74(8):2258-69. PubMed ID: 24566868
[TBL] [Abstract][Full Text] [Related]
8. Chromatin-remodeling factor, RSF1, controls p53-mediated transcription in apoptosis upon DNA strand breaks.
Min S; Kim K; Kim SG; Cho H; Lee Y
Cell Death Dis; 2018 Oct; 9(11):1079. PubMed ID: 30348983
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of hSNF2H in glioma promotes cell proliferation, invasion, and chemoresistance through its interaction with Rsf-1.
Zhao XC; An P; Wu XY; Zhang LM; Long B; Tian Y; Chi XY; Tong DY
Tumour Biol; 2016 Jun; 37(6):7203-12. PubMed ID: 26666816
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA SNHG6 Promotes Proliferation and Inhibits Apoptosis in Non-small Cell Lung Cancer Cells by Regulating miR-490-3p/RSF1 Axis.
Dong Z; Liu H; Zhao G
Cancer Biother Radiopharm; 2020 Jun; 35(5):351-361. PubMed ID: 32202941
[No Abstract] [Full Text] [Related]
11. The roles of human sucrose nonfermenting protein 2 homologue in the tumor-promoting functions of Rsf-1.
Sheu JJ; Choi JH; Yildiz I; Tsai FJ; Shaul Y; Wang TL; Shih IeM
Cancer Res; 2008 Jun; 68(11):4050-7. PubMed ID: 18519663
[TBL] [Abstract][Full Text] [Related]
12. Recurrent amplification at 7q21.2 Targets CDK6 gene in primary myxofibrosarcomas and identifies CDK6 overexpression as an independent adverse prognosticator.
Tsai JW; Li CF; Kao YC; Wang JW; Fang FM; Wang YH; Wu WR; Wu LC; Hsing CH; Li SH; Yu SC; Lan J; Huang HY
Ann Surg Oncol; 2012 Aug; 19(8):2716-25. PubMed ID: 22476749
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implication of MET overexpression in myxofibrosarcomas: an integrative array comparative genomic hybridization, real-time quantitative PCR, immunoblotting, and immunohistochemical analysis.
Lee JC; Li CF; Fang FM; Wang JW; Jeng YM; Yu SC; Lin YT; Wu JM; Tsai JW; Li SH; Huang HY
Mod Pathol; 2010 Oct; 23(10):1379-92. PubMed ID: 20639860
[TBL] [Abstract][Full Text] [Related]
14. High RSF1 protein expression is an independent prognostic feature in prostate cancer.
Höflmayer D; Hamuda M; Schroeder C; Hube-Magg C; Simon R; Göbel C; Hinsch A; Weidemann S; Möller K; Izbicki JR; Jacobsen F; Mandelkow T; Blessin NC; Lutz F; Viehweger F; Sauter G; Burandt E; Lebok P; Lennartz M; Fraune C; Minner S; Bonk S; Huland H; Graefen M; Schlomm T; Büscheck F
Acta Oncol; 2020 Mar; 59(3):268-273. PubMed ID: 31687881
[No Abstract] [Full Text] [Related]
15. Human CCAAT/enhancer-binding protein β interacts with chromatin remodeling complexes of the imitation switch subfamily.
Steinberg XP; Hepp MI; Fernández García Y; Suganuma T; Swanson SK; Washburn M; Workman JL; Gutiérrez JL
Biochemistry; 2012 Feb; 51(5):952-62. PubMed ID: 22242598
[TBL] [Abstract][Full Text] [Related]
16. CCAAT enhancer binding protein-beta regulates matrix metalloproteinase-1 expression in interleukin-1beta-stimulated A549 lung carcinoma cells.
Armstrong DA; Phelps LN; Vincenti MP
Mol Cancer Res; 2009 Sep; 7(9):1517-24. PubMed ID: 19723873
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1β mediates metalloproteinase-dependent renal cell carcinoma tumor cell invasion through the activation of CCAAT enhancer binding protein β.
Petrella BL; Vincenti MP
Cancer Med; 2012 Aug; 1(1):17-27. PubMed ID: 23342250
[TBL] [Abstract][Full Text] [Related]
18. Characterization of gene amplification-driven SKP2 overexpression in myxofibrosarcoma: potential implications in tumor progression and therapeutics.
Li CF; Wang JM; Kang HY; Huang CK; Wang JW; Fang FM; Wang YH; Wu WR; Li SH; Yu SC; Lee JC; Lan J; Shiue YL; Wu LC; Huang HY
Clin Cancer Res; 2012 Mar; 18(6):1598-610. PubMed ID: 22322669
[TBL] [Abstract][Full Text] [Related]
19. RSF1 and not cyclin D1 gene amplification may predict lack of benefit from adjuvant tamoxifen in high-risk pre-menopausal women in the MA.12 randomized clinical trial.
Keilty D; Buchanan M; Ntapolias K; Aleynikova O; Tu D; Li X; Shepherd L; Bramwell V; Basik M
PLoS One; 2013; 8(12):e81740. PubMed ID: 24367492
[TBL] [Abstract][Full Text] [Related]
20. Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.
Li CF; Fang FM; Kung HJ; Chen LT; Wang JW; Tsai JW; Yu SC; Wang YH; Li SH; Huang HY
Oncotarget; 2014 Nov; 5(22):11428-41. PubMed ID: 25426549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
